Fresh Recalls

FDAClass II · Drug · Recall D-0514-2026 · Recalled May 13, 2026

Duloxetine Delayed-Release Capsules recall — Ajanta Pharma Ltd.

Agency report date: May 13, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Duloxetine Delayed-Release Capsules
Company / brand
Ajanta Pharma
Lot / serial / date codes
Lot#: a) PA10774, Exp. May 2026; b) PA10794, PA12174, Exp. Jun 2026; c) PA10804, Exp. Jun-26.
Distribution
Nationwide within U.S
Agency product description and boundaries

Duloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30 capsules, NDC 27241-098-03, c) 1000 Capsules, NDC 27241-098-10, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Duloxetine Delayed-Release Capsules recall status

3. Open the official notice or contact

Official recall ID
D-0514-2026
Brand
All Ajanta Pharma recalls
Classification
Class II
Units affected
312,894 packs
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Aurangabad, India
Firm address
B-4/5/6 MIDC Industrial Area, Paithan, N/A

Identifying details (verbatim from the notice)

Product codes / lots
Lot#: a) PA10774, Exp. May 2026; b) PA10794, PA12174, Exp. Jun 2026; c) PA10804, Exp. Jun-26.
Distribution
Nationwide within U.S
Firm notified the public via
Letter
FDA event ID
98785
Recall initiated
April 29, 2026
FDA classified
May 4, 2026
FDA report date
May 13, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved August 11, 2026 at 6:00 PM UTC.

Report a data error on this page